| VTE | venous thromboembolism |
| H&N | head and neck |
| SCC | squamous cell carcinoma |
| MPs | microparticules |
| TF | tissue factor |
| TFPI | tissue factor pathway inhibitor |
| OSCC | oral squamous cell carcinoma |
| ASCO | American Society of Clinical Oncology |
| LMWH | low molecular weight heparin |
| VKA | vitamin K antagonist |
| tPA | tissue plasminogen activators |
| uPA | urokinase plasminogen activators |
| PAI | plasminogen activator inhibitor |
| TAFI | thrombin activated fibrinolysis inhibitor |
| ELISA | enzyme-linked immunosorbent assays |
| TXA2 | thromboxane A2 |
| PGI2 | prostacyclin |
| vWF | von Willebrand factor |
| TM | thrombomodulin |
| TNF | tumor necrosis factor |
| IL | interleukin |
| VEGF | vascular endothelial growth factor |
| GM-CSF | granulocyte-macrophage colony-stimulating factor |
| EGF | epidermal growth factor |
| PDGF | platelet-derived growth factor |
| TGFβ | transforming growth factor |